OSHA Reveals Top 10 Safety Violations at NSC Safety Congress & Expo
Fall Protection remains top citation for 13th year in a row
NEW ORLEANS, Oct. 24, 2023 /PRNewswire/ -- The Occupational Safety and Health Administration on Tuesday announced its most frequently cited workplace safety standards for fiscal year 2023.
Eric Harbin, OSHA Region 6 administrator, presented the preliminary data for "OSHA's Top 10" during the 2023 NSC Safety Congress & Expo, the world's largest annual gathering of safety professionals.
Fall Protection ? General Requirements remains at the top of the list for the 13th year in a row, followed by Hazard Communication and Ladders.
"Although incredible advancements are made in safety each year, we continue to see many of the same types of violations appear on OSHA's Top 10 list," said Lorraine Martin, NSC president and CEO. "As a safety community, we must come together to acknowledge these persistent trends and identify solutions to better protect workers."
The Top 10 most frequently cited workplace safety standards for FY 2023, which ended Sept. 30, are:
Fall Protection ? General Requirements (1926.501): 7,271 violations
Hazard Communication (1910.1200): 3,213
Ladders (1926.1053): 2,978
Scaffolding (1926.451): 2,859
Powered Industrial Trucks (1910.178): 2,561
Lockout/Tagout (1910.147): 2,554
Respiratory Protection (1910.134): 2,481
Fall Protection ? Training Requirements (1926.503): 2,112
Personal Protective and Lifesaving Equipment ? Eye and Face Protection (1926.102): 2,074
Machine Guarding (1910.212): 1,644
A more in-depth analysis of the Top 10 violations for 2023 will be published in the December edition of Safety+Health magazine, a National Safety Council publication.
About the National Safety Council The National Safety Council is America's leading nonprofit safety advocate ? and has been for 110 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace and roadways. We create a culture of safety to not only keep people safer at work, but also beyond the workplace so they can live their fullest lives.
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia.
The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...
A news report from China Daily:
The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations.
The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...